High titres of rat interferon (IFN) can be produced by rat embryo fibroblast (CD) cells after treatment with Newcastle disease virus. This CD IFN was characterized by SDS–PAGE, and was found to contain three species at 30K to 33K, 25K to 27K and 17K to 22K mol. wt. Antibody affinity chromatography revealed that 95% of the CD IFN bound to an anti-human leukocyte IFN antibody column, 34% to an anti-mouse L cell IFN antibody column and none to an anti-human fibroblast IFN antibody column. The IFN that bound to the anti-human leukocyte IFN antibody column contained all three molecular weight species of IFN. However, the material bound to the anti-mouse L cell IFN antibody column only showed IFN activity of the 30K and 20K species. Examination of the heterologous antiviral activity of the unseparated CD IFN and of the IFN separated by antibody affinity chromatography revealed the same patterns of activity: 35 to 50% of homologous activity on guinea-pig cells, 10 to 20% on mouse cells, 2 to 4% on human cells and none on bovine cells. The data suggest that a major portion of this rat fibroblast IFN is related to alpha IFNs produced by other species.
BilliauA.,
HeremansH.,
VeruerkenD.,
Van DammeJ.,
CartonH.,
De SomerP.1981; Tissue distribution of human interferons after exogenous admininstration in rabbits, monkeys and mice. Archives of Virology 68:19–25
BohlinP.,
SteinS.,
DairmanW.,
UdenfriendS.1973; Fluorimetric assay of proteins in the nanogram range. Archives of Biochemistry and Biophysics 155:213–220
DavisC. T.,
RusckowskiM.,
GoldsteinD. A.,
MuraskoD. M.1984; Production and partial purification of rat fibroblast-derived interferon induced in a newly established cell line. Journal of Interferon Research 4:365–374
Demaeyer-GuignardJ.,
Nguy ThangM.,
DemaeyerE.1977; Binding of mouse interferon to polynucleotides. Proceedings of the National Academy of Sciences, U. S. A 74:3787–3791
DukemaR.,
PouwelsP.,
De ReusA.,
SchellekensH.1984; Structure and expression in Escherichia coli of a cloned rat interferon alpha gene. Nucleic Acids Research 12:1227–1242
EarleW. R.1943; Production of malignancy in vitro. IV. The mouse fibroblast cultures and changes seen in the living cells. Journal of the National Cancer Institute 4:165–172
LobodzinskaM.,
BiernackaI.,
SkurskaZ.1973; Rat interferon. I. Biological properties of interferons in rat serum. Archivum Immunologiae et Therapiae Experimentalis 21:461–469
LobodzinskaM.,
BiernackaI.,
SkurskaZ.1975; Rat interferons. III. Anti-viral activity and effect of priming on interferon production in homologous and heterologous cell lines. Archivum Immunologiae et Therapiae Experimentalis 23:225–231
PauckerK.,
DaltonB. J.,
OgburnC. A.,
TormaE.1975; Multiple active sites on human interferons. Proceedings of the National Academy of Sciences, U. S. A 72:4587–4591
SchellekensH.,
De WildeG. A.,
De ReusA.1981; Relationship between the cellular expression of the antiviral and anti-cellular activities of interferon. Antiviral Research 1:135–140
StewartW. E.II,
HavellE. A.1980; Characterization of a subspecies of mouse interferon cross-reactive on human cells and antigenically related to human leukocyte interferon. Virology 101:315–320